Forwarded from PDFology (Basem Medhat)
Beta blocker- partI.pdf
8 MB
تفريغ د عبد المتعال فودة
ANS
Part1: Beta adrenergic blockers
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
ANS
Part1: Beta adrenergic blockers
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
Forwarded from PDFology (Basem Medhat)
Beta blocker- partII_compressed (1).pdf
5.1 MB
تفريغ د عبد المتعال فودة
ANS
Part2: beta adrenergic blockers
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
ANS
Part2: beta adrenergic blockers
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
Photo
إيه الفرق بين
Thalassemia vs iron deficiency anemia?
### Thalassemia:
🔹 Genetic Disorder:
- Thalassemia is primarily a genetic disorder caused by mutations in the genes responsible for hemoglobin production.
🔹 Reduced Hemoglobin Synthesis:
- Individuals with thalassemia have reduced synthesis of hemoglobin, leading to fewer healthy red blood cells.
🔹 Inherited Condition:
- Thalassemia is inherited from parents who carry mutated genes related to hemoglobin production.
🔹 Chronic Anemia:
- It causes chronic anemia, which can range from mild to severe depending on the type and number of affected genes.
🔹 Treatment Options:
- Treatment may involve blood transfusions, iron chelation therapy, and, in some cases, bone marrow transplantation.
### Iron Deficiency Anemia:
🔸 Iron Deficiency:
- Iron deficiency anemia results from inadequate iron levels in the body, leading to decreased hemoglobin production.
🔸 Multiple Causes:
- Causes include insufficient dietary intake of iron, poor absorption of iron, blood loss (chronic or acute), or increased iron requirements.
🔸 Common Nutritional Deficiency:
- It is one of the most common nutritional deficiencies worldwide.
🔸 Treatment with Iron Supplements:
- Treatment involves iron supplementation, dietary changes to include iron-rich foods, and addressing underlying causes like gastrointestinal bleeding or menstrual disorders.
🔸 Reversible Condition:
- Iron deficiency anemia is often reversible with proper treatment and addressing the underlying cause.
📚 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
Thalassemia vs iron deficiency anemia?
### Thalassemia:
🔹 Genetic Disorder:
- Thalassemia is primarily a genetic disorder caused by mutations in the genes responsible for hemoglobin production.
🔹 Reduced Hemoglobin Synthesis:
- Individuals with thalassemia have reduced synthesis of hemoglobin, leading to fewer healthy red blood cells.
🔹 Inherited Condition:
- Thalassemia is inherited from parents who carry mutated genes related to hemoglobin production.
🔹 Chronic Anemia:
- It causes chronic anemia, which can range from mild to severe depending on the type and number of affected genes.
🔹 Treatment Options:
- Treatment may involve blood transfusions, iron chelation therapy, and, in some cases, bone marrow transplantation.
### Iron Deficiency Anemia:
🔸 Iron Deficiency:
- Iron deficiency anemia results from inadequate iron levels in the body, leading to decreased hemoglobin production.
🔸 Multiple Causes:
- Causes include insufficient dietary intake of iron, poor absorption of iron, blood loss (chronic or acute), or increased iron requirements.
🔸 Common Nutritional Deficiency:
- It is one of the most common nutritional deficiencies worldwide.
🔸 Treatment with Iron Supplements:
- Treatment involves iron supplementation, dietary changes to include iron-rich foods, and addressing underlying causes like gastrointestinal bleeding or menstrual disorders.
🔸 Reversible Condition:
- Iron deficiency anemia is often reversible with proper treatment and addressing the underlying cause.
📚 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
Photo
💊 علاج للضغط كل ست شهور!
📋 Zilebesiran is an exciting new drug currently under development for the treatment of hypertension (high blood pressure). Here's a breakdown of the key details:
🔍 What it is:
* Zilebesiran is an investigational RNA interference (RNAi) therapeutic. RNAi is a technology that can silence specific genes.
* In this case, zilebesiran targets the gene for angiotensinogen, a protein involved in regulating blood pressure. By reducing angiotensinogen levels, zilebesiran aims to lower blood pressure.
🛠️ How it works:
* Zilebesiran is delivered subcutaneously, meaning it's injected under the skin.
* It utilizes a specific technology called ESC+ GalNAc-conjugate, which allows for infrequent dosing (potentially twice-yearly or quarterly).
* Early studies suggest a single dose can effectively reduce blood pressure for up to six months.
📊 What the research shows:
* Phase 2 clinical trials have shown promise. A single dose of zilebesiran significantly lowered both systolic and diastolic blood pressure for up to 24 weeks in people with mild-to-moderate hypertension.
* The reduction in blood pressure was consistent throughout the day and night, which is important for optimal blood pressure control.
* The study also found zilebesiran to be well-tolerated, with only mild injection site reactions reported.
⚠️ Important things to note:
* Zilebesiran is still under development, and further studies are needed to confirm its efficacy and safety in larger populations.
* It's not yet available for prescription.
* If you have high blood pressure, it's crucial to consult with your doctor about the best treatment options for you.
🌐 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
📋 Zilebesiran is an exciting new drug currently under development for the treatment of hypertension (high blood pressure). Here's a breakdown of the key details:
🔍 What it is:
* Zilebesiran is an investigational RNA interference (RNAi) therapeutic. RNAi is a technology that can silence specific genes.
* In this case, zilebesiran targets the gene for angiotensinogen, a protein involved in regulating blood pressure. By reducing angiotensinogen levels, zilebesiran aims to lower blood pressure.
🛠️ How it works:
* Zilebesiran is delivered subcutaneously, meaning it's injected under the skin.
* It utilizes a specific technology called ESC+ GalNAc-conjugate, which allows for infrequent dosing (potentially twice-yearly or quarterly).
* Early studies suggest a single dose can effectively reduce blood pressure for up to six months.
📊 What the research shows:
* Phase 2 clinical trials have shown promise. A single dose of zilebesiran significantly lowered both systolic and diastolic blood pressure for up to 24 weeks in people with mild-to-moderate hypertension.
* The reduction in blood pressure was consistent throughout the day and night, which is important for optimal blood pressure control.
* The study also found zilebesiran to be well-tolerated, with only mild injection site reactions reported.
⚠️ Important things to note:
* Zilebesiran is still under development, and further studies are needed to confirm its efficacy and safety in larger populations.
* It's not yet available for prescription.
* If you have high blood pressure, it's crucial to consult with your doctor about the best treatment options for you.
🌐 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
Forwarded from PDFology (Basem Medhat)
Antidepressant drugs.pdf
12.3 MB
تفريغ د عبد المتعال فودة CNS
Lecture: 11
Antidepressant drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
Lecture: 11
Antidepressant drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸